Cholinergic urticaria in pediatricians’ practice
https://doi.org/10.24412/2500-1175-2021-2-31-36
Abstract
Chronic urticaria (CholU) is a relevant problem in pediatrics due to its high frequency among other physical forms of chronic urticarial especially in adolescence. We present current data of pathogenesis, diagnostic criterias and principles of therapy of CholU using up-to-date clinical guidelines. Also the significance of provocative tests for diagnosis and differential diagnosis with other forms of inducible urticaria was described. We examined 182 patients with chronic urticarial and revealed 3.8% cases of CholU. Our clinical case report of patient with cold urticaria and exercise-induced anaphylaxis represents the importance of this issue for pediatricians and allergists-immunologists.
About the Authors
R. F. KhakimovaRussian Federation
Rezeda F. Khakimova, Professor of the Department of Clinical Immunology and Allergology
49, Butlerov Str., Kazan, 420012, Russia
O. V. Skorokhodkina
Russian Federation
Kazan
A. R. Klucharova
Russian Federation
Kazan
References
1. Magerl M., Altrichter S., E Borzova E. et al. The definition, diagnostic testing, and management of chronic inducible urticarias — The EAACI/GA (2) LEN/EDF/UNEV consensus recommendations 2016 update and revision // Allergy. 2016; 71 (6): p. 780–802. DOI: 10.1111/all.12884.
2. Montgomery S.L. Cholinergic urticaria and exercise-induced anaphylaxis. // Curr Sports Med Rep. 2015; 14: p. 61–63. DOI: 10.1249/JSR.0000000000000111.
3. Krapivnica i angiotek: rekomendacii dlya praktikuyushchih vrachej. Rossijskij nacional'nyj soglasitel'nyj dokument. Moskva. Farmus Print Media, 2007, 127 p. (In Russ)
4. Zuberbier T1., Althaus C., Chantraine-Hess S., Czarnetzki B.M. Prevalence of cholinergic urticaria in young adults // J Am Acad Dermatol. 1994; Dec; 31(6): p. 978–81. DOI: 10.1016/s0190-9622(94)70267-5.
5. Nakamizo S., Egawa G., Miyachi Y., Kabashima K. Cholinergic urticaria: pathogenesis-based categorization and its treatment options // J Eur Acad Dermatol Venereol. 2012 Jan; 26(1): p. 114–116. DOI: 10.1111/J.1468-3083.2011/04017.x.
6. Sawada Y., Nakamura M., Bito T. et al. Cholinergic urticaria: studies on the muscarinic cholinergic receptor M3 in the anhidrotic and hypohidrotic skin // J Invest Dermatol. 2010 Nov; 130(11): p. 2683–2686. DOI: 10.1038/jid.2010.188.
7. Adachi J., Aoki T., Yamatodani A. Demonstration of sweat allergy in cholinergic urticarial // J Dermatol Sci. 1994 Apr; 7(2): p. 142–149. DOI: 10.1016/0923-1811(94)90088-4.
8. Yoshiki T., Yokozeki H., Murota H., Katayama I. (eds). New Etiology of Cholinergic Urticaria: Perspiration Research // Curr Probl Dermatol. Basel, Karger, 2016, vol. 51: p. 94–100.
9. Kobayashi H., Aiba S., Yamagishi T. et al. Cholinergic urticaria, a new pathogenic concept: hypohidrosis due to interference with the delivery of sweat to the skin surface // Dermatology. 2002; 204(3): p. 173–178. DOI: 10.1159/000057877.
10. Ménard S., Cerf-Bensussan N., Heyman M. Multiple facets of intestinal permeability and epithelial handling of dietary antigens // Mucosal Immunol. 2010 May; 3(3): p. 247–259. DOI: 10.1038/mi.2010.5.
11. Vadas P., Sinilaite A., Chaim M. Cholinergic Urticaria with Anaphylaxis: An Underrecognized Clinical Entity // J Allergy Clin Immunol Pract. Mar-Apr 2016; 4(2): p. 284–291. DOI: 10.1016/j.jaip.2015.09.021.
12. Klinicheskie recomendacii «Krapivnica», 2019. https://raaci.ru/dat/pdf/urticaria-project.pdf (In Russ)
13. Altrichter S., Salow J., Ardelean E., Church M.K., Werner A., Maurer M. Development of a standardized pulsecontrolled ergometry test for diagnosing and investigating cholinergic urticarial // J Dermatol Sci. 2014; 75: p. 88–93. DOI: 10.1016/j.jdermsci.2014.04.007.
14. Atsushi Fukunaga, MD, Toshinori Bito, MD, Kenta Tsuru, MD, Akiko Oohashi, MD, Xijun Yu, MD, Masamitsu Ichihashi, MD, Chikako Nishigori, MD, and Tatsuya Horikawa, MD. Responsiveness to autologous sweat and serum in cholinergic urticarial classifies its clinical subtypes // J Allergy and clinical immunology. Vol. 116, Issue 2, p. 397–402.
15. Zuberbier T., Aberer W., Asero R. et al. The EAACI/GA2 LEN/EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update // Allergy. 2018. Jul; 73(7): p. 1393–1414. DOI: 10.1111/all.13397.
16. Metz M., Bergmann P., Zuberbier T., Maurer M. Successful treatment of cholinergic urticaria with antiimmunoglobulin E therapy // Allergy. 2008; 63: p. 247–249. DOI: 10.1111/j.1398-9995.2007.01591.x.
17. Kutlu A., Tanoglu A., Ozturk S. Healing effects of omalizumab in a patient with cholinergic urticaria associated severe dyspeptic complaints // Chin Med J (Engl). 2015; 128: p. 1559–1560. DOI: 10.4103/0366-6999.157703.
18. Allergologiya i klinicheskaya immunologiya. Klinicheskie rekomendacii. Pod redakciej akad. RAN R.M. Haitova, prof. N.I. Il'inoj. M.: GEOTAR-Media. 2019. 335 p. (P. 214–241) (In Russ)
19. Kozaru T., Fukunaga A., Taguchi K., Ogura K., Nagano T., Oka M. et al. Rapid desensitization with autologous sweat in cholinergic urticarial // Allergol Int. 2011; 60: p. 277–281. DOI: 10.2332/allergolint.10-OA-0269.
Review
For citations:
Khakimova R.F., Skorokhodkina O.V., Klucharova A.R. Cholinergic urticaria in pediatricians’ practice. Allergology and Immunology in Paediatrics. 2021;(2):31-36. (In Russ.) https://doi.org/10.24412/2500-1175-2021-2-31-36